Ryanodine receptors are involved in the improvement of depression-like behaviors through electroconvulsive shock in stressed mice.
Ryanodine receptors are involved in the improvement of depression-like behaviors through electroconvulsive shock in stressed mice.
复制标题
Ryanodine 受体通过应激小鼠的电休克来改善抑郁样行为。
DOI:
10.1016/j.brs.2020.11.001
复制
发表时间:
2021
影响因子:
7.7
通讯作者:
Miyamoto O
中科院分区:
文献类型:
--
作者:
91.Nakamura-Maruyama E;Kai R;Himi N;Okabe N;Narita K;Miyazaki T;Aoki S;Miyamoto O
BackgroundElectroconvulsive therapy (ECT) is effective for treating depression. However, the mechanisms underlying the antidepressant effects of ECT remain unknown. Depressed patients exhibit abnormal Ca2+kinetics. Early stages of the intracellular Ca2+signaling pathway involve the release of Ca2+from the endoplasmic reticulum (ER) via Ca2+release channels.ObjectiveWe considered that depression may be improved via ECT-induced normalization of intracellular Ca2+regulation through the Ca2+release channels. The current study aimed to investigate the effects of ECT on two Ca2+release channels, ryanodine receptors (RyRs) and inositol 1,4,5-trisphosphate receptors (IP3Rs).MethodsA mouse depression-like model subjected to water immersion with restraint stress was administered electroconvulsive shock (ECS) therapy. Their depression-like status was behaviorally and histologically assessed using forced swimming tests, novelty-suppressed feeding tests, and by evaluating neurogenesis in the hippocampal dentate gyrus, respectively. A RyRs blocker, dantrolene, was administered prior to ECS, and the changes in depression-like conditions were examined.ResultsThe protein expressions of RyR1 and RyR3 significantly increased in the hippocampus of the mouse model with depression-like symptoms. This increase was attenuated as depression-like symptoms were reduced due to ECS application. However, pre-injection with dantrolene reduced the antidepressant effects of ECS.ConclusionsA significant increase in RyRs expression in a depression-like state and exacerbation of depression-like symptoms by RyRs inhibitors may be caused by RyRs dysfunction, suggesting overexpression of RyRs is a compensatory effect. Normalization of RyRs expression levels by ECS suggests that ECT normalizes the Ca2+release via RyRs. Thus, normalizing the function of RyRs may play an important role in the therapeutic effect of ECT.